A two-year follow-up of 181 sputum-positive tuberculosis patients treated in Gateshead between 1961 and 1966.
D000636:Aminosalicylic Acids / Q000009:adverse effects / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004342:Drug Hypersensitivity; D004352:Drug Resistance, Microbial; D004739:England; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D013307:Streptomycin / Q000009:adverse effects / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000382:microbiology / Q000401:mortality
D000636:Aminosalicylic Acids; D000995:Antitubercular Agents; D007538:Isoniazid; D013307:Streptomycin